References
- Alexander B., Goldstein R., Landwehr G. The prothrombin conversion accelerator of serum (SPCA): Its partial purification and its properties compared with serum AC-globulin. J. clin. Invest 1950; 29: 881
- Deutsch E., Schaden W. Zur Reinigung und Charakterisierung des VII. Blutgerinnungs-faktors. Biochem. Z 1953; 324: 266
- Furberg S., Mostad A. The crystal structure of Ba-Ribose-5-phosphate. Acta chem. scand 1962; 16: 1627
- Hjort P. F. Intermediate reactions in the coagulation of blood with tissue thromboplastin. Scand. J. clin. Lab. Invest 1957; 9, Suppl. 27
- Kabat E. A., Mayer M. M. Experimental Immunochemistry.2nd ed. Thomas Charles C., Springfield IllinoisUSA 1961; 905
- Owren P. A. (1951) The prothrombin activating complex and its clinical significance. Proc. 3rd Congr. Int. Soc. Haematol., Cambridge, England, 1950. Grune & Stratton, New York, 379
- Prydz H. Studies on proconvertin I: Gel filtration. Scand. J. clin. Lab. Invest 1963; 15: 450
- Prydz H. Studies on proconvertin II: Purification. Ibid 1964; 16: 1
- Tishkoff G. H., Pechet L., Alexander B. Some biochemical and electrophoretic studies on purified prothrombin, factor VII (Proconvertin) and factor X (Stuart). Blood 1960; 16: 778
- Zittle C. A. Absorption studies of enzymes and other proteins. Advances in Enzymology, F. F. Nord. Interscience Publishers Inc., New York 1953; 14: 319